Brief: FDA Approves First Generic Of Drug Used To Treat Severe Hypoglycemia
Dec 28 (Reuters) - FDA:
* FDA - APPROVES FIRST GENERIC OF DRUG USED TO TREAT SEVERE
HYPOGLYCEMIA
* FDA - FDA GRANTED APPROVAL OF THIS GENERIC GLUCAGON FOR
INJECTION TO AMPHASTAR PHARMACEUTICALS, INC. OF RANCHO
CUCAMONGA, CALIF
Source text: [https://bit.ly/3aPuil9]
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Amphastar Pharmaceuticals
See all newsAmphastar Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary
Brief: Amphastar Pharmaceuticals Q2 EPS USD 0.67
U.S. STOCKS ON THE MOVE-RBB Bancorp, Roblox, Open Lending
U.S. STOCKS ON THE MOVE-Amkor Technology, Dynatrace, Corvex
Amphastar rises after FDA approves new over-the-counter overdose spray